Nada Boudiaf

565 total citations
13 papers, 349 citations indexed

About

Nada Boudiaf is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Nada Boudiaf has authored 13 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Nada Boudiaf's work include Respiratory and Cough-Related Research (5 papers), Asthma and respiratory diseases (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Nada Boudiaf is often cited by papers focused on Respiratory and Cough-Related Research (5 papers), Asthma and respiratory diseases (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Nada Boudiaf collaborates with scholars based in United States, United Kingdom and Spain. Nada Boudiaf's co-authors include Robert Suruki, Frank C. Albers, Linda Kalilani, Mahnaz Asgharnejad, David Friesen, Héctor Ortega, Gino Picelli, Peter R. Rijnbeek, Francesco Lapi and Elisabeth Svensson and has published in prestigious journals such as PLoS ONE, Neurology and Thorax.

In The Last Decade

Nada Boudiaf

11 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nada Boudiaf United States 8 251 208 33 26 24 13 349
Agustí Comella Spain 7 300 1.2× 234 1.1× 32 1.0× 9 0.3× 23 1.0× 15 403
Michael J. Akerman United States 7 186 0.7× 116 0.6× 26 0.8× 9 0.3× 11 0.5× 13 319
Li Ping Chung Australia 11 261 1.0× 272 1.3× 18 0.5× 4 0.2× 23 1.0× 18 419
Nick Adams United Kingdom 13 485 1.9× 476 2.3× 13 0.4× 11 0.4× 57 2.4× 20 601
Felipe Cortopassi United States 11 126 0.5× 376 1.8× 18 0.5× 11 0.4× 9 0.4× 23 438
Aikaterini Haniotou Greece 7 100 0.4× 217 1.0× 23 0.7× 12 0.5× 5 0.2× 14 304
N.H.T. ten Hacken Netherlands 5 200 0.8× 255 1.2× 17 0.5× 4 0.2× 4 0.2× 8 372
Maria C. Zoia Italy 10 219 0.9× 402 1.9× 60 1.8× 15 0.6× 45 1.9× 13 523
Philippa Shirtcliffe New Zealand 10 500 2.0× 458 2.2× 20 0.6× 3 0.1× 22 0.9× 17 648
FM Ducharme Canada 12 386 1.5× 352 1.7× 19 0.6× 3 0.1× 53 2.2× 14 462

Countries citing papers authored by Nada Boudiaf

Since Specialization
Citations

This map shows the geographic impact of Nada Boudiaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Boudiaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Boudiaf more than expected).

Fields of papers citing papers by Nada Boudiaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Boudiaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Boudiaf. The network helps show where Nada Boudiaf may publish in the future.

Co-authorship network of co-authors of Nada Boudiaf

This figure shows the co-authorship network connecting the top 25 collaborators of Nada Boudiaf. A scholar is included among the top collaborators of Nada Boudiaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Boudiaf. Nada Boudiaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
4.
Engelkes, Marjolein, Maria de Ridder, Elisabeth Svensson, et al.. (2020). Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study. Pediatric Allergy and Immunology. 31(5). 496–505. 27 indexed citations
5.
Engelkes, Marjolein, Elisabeth Svensson, Klára Berencsi, et al.. (2020). Multinational cohort study of mortality in patients with asthma and severe asthma. Respiratory Medicine. 165. 105919–105919. 45 indexed citations
6.
Borghs, Simon, et al.. (2020). Cost of epilepsy-related health care encounters in the United States. Journal of Managed Care & Specialty Pharmacy. 26(12). 1576–1581. 9 indexed citations
7.
Kalilani, Linda, David Friesen, Nada Boudiaf, & Mahnaz Asgharnejad. (2019). The characteristics and treatment patterns of patients with Parkinson’s disease in the United States and United Kingdom: A retrospective cohort study. PLoS ONE. 14(11). e0225723–e0225723. 26 indexed citations
8.
Suruki, Robert, et al.. (2017). The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulmonary Medicine. 17(1). 74–74. 198 indexed citations
9.
Suruki, Robert, Nada Boudiaf, & Héctor Ortega. (2016). Retrospective cohort analysis of healthcare claims in the United States characterising asthma exacerbations in paediatric patients. World Allergy Organization Journal. 9. 18–18. 17 indexed citations
10.
DiSantostefano, Rachael L., Nada Boudiaf, David A. Stempel, Neil Barnes, & A P Greening. (2016). The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis. npj Primary Care Respiratory Medicine. 26(1). 16038–16038. 5 indexed citations
11.
12.
Requena, Gema, John Logie, Elisa Martín‐Merino, et al.. (2015). Do case‐only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines. Pharmacoepidemiology and Drug Safety. 25(S1). 79–87. 10 indexed citations
13.
Irizarry, Michael C., David R. Webb, Nada Boudiaf, et al.. (2011). Risk of cancer in patients exposed to gabapentin in two electronic medical record systems. Pharmacoepidemiology and Drug Safety. 21(2). 214–225. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agustí Comella Breakdown of academic impact, for papers by Michael J. Akerman Breakdown of academic impact, for papers by Li Ping Chung Breakdown of academic impact, for papers by Nick Adams Breakdown of academic impact, for papers by Felipe Cortopassi Breakdown of academic impact, for papers by Aikaterini Haniotou Breakdown of academic impact, for papers by N.H.T. ten Hacken Breakdown of academic impact, for papers by Maria C. Zoia Breakdown of academic impact, for papers by Philippa Shirtcliffe Breakdown of academic impact, for papers by FM Ducharme
Rankless by CCL
2026